Industry news: Valeant buys Aton (aka Lacrisert company)

On May 27th, Valeant Pharmaceuticals completed the purchase of Aton Pharma. Aton had acquired Lacrisert from Merck and has breathed new life into Lacrisert.

Valeant Pharmaceuticals Completes Acquisition of Aton Pharma, Inc.

ALISO VIEJO, Calif., May 27, 2010 /PRNewswire via COMTEX/ --Valeant Pharmaceuticals International (NYSE: VRX) today announced that effective May 26, 2010, the company completed its acquisition of Aton Pharma, Inc., a specialty pharmaceutical company focused on ophthalmology and certain orphan drug indications, located in Lawrenceville, New Jersey.